Aillis

Tokyo, Japan · Founded 2017 · Privately Held (backing)

Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. Aillis is based in Tokyo, Japan and was founded in 2017. Its last reported valuation was $125 million in Apr 2025. It has raised $54.6 million.

Last reported valuation
$125.2M
Oct 2026
Priced at
—
Total raised
$54.6M
Last round
—

Who backs Aillis?

27 investors
InvestorType
J-StartupOther
Nissay CapitalOther
Z Venture CapitalOther
Pegasus Tech VenturesVenture capital
Mirai Creation CapitalVenture capital
Mitsui Sumitomo Insurance Co.Other
Aozora Corporate InvestmentOther
Beyond Next VenturesVenture capital
HiJoJo PartnersVenture capital
JP Life Next FundVenture capital
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aillis investors

27 investors are on record for Aillis, including J-Startup, Nissay Capital, Z Venture Capital and Pegasus Tech Ventures. By type, the record holds 5 venture capital firms.

Free account
More of Aillis with a free account
  • ·The complete investor list: 27 names
  • ·Watch Aillis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Aillis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View